Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Tailoring the plasmonic properties of gold-liposome nanohybrids as a potential powerful tool for light-mediated therapies

  • Rubio-Camacho, Marta
  • Martínez-Tomé, María José
  • Cuestas-Ayllón, Carlos
  • Fuente, Jesús M. de la
  • Esquembre, Rocío
  • Reyes Mateo, C.
A fast and environmentally-friendly methodology has been developed by in situ synthesis of gold nanoparticles (AuNPs) on thermosensitive liposomes in different phase-states, obtaining nanohybrids with controllable and tunable plasmon modes within the visible/near-infrared region. Lipid phase, charge and synthesis temperature influence the final arrangement of AuNPs, so when the synthesis is performed on zwitterionic liposomes in fluid phase, discrete AuNPs with plasmon peaks in the visible region are obtained, while in gel phase AuNPs tend to aggregate forming nanoclusters, leading to plasmon bands gradually shifted to the infrared as the synthesis temperature decreases. The formed nanohybrids retain the physical properties of the liposomes (fluidity, degree of hydration, cooperativity) by maintaining the transition temperature in the mild-hyperthermia range, while preserving their light-to-heat conversion properties. Therefore, these nanohybrids can be considered excellent candidates as versatile photothermal agents with controlled drug delivery capacity, being powerful tools for light-mediated therapies., This work was funded by the Spanish MINECO (MAT-2017-86805-R to C.R.M and PID2020-118485-RB-I00 to J.M.F), DGA and Fondos Feder (Bionanosurf E15_17R to J.M.F) and CIBER-Consorcio Centro de Investigación Biomédica en Red (CB16/01/00263 to J.M.F and C.C.A), Instituto de Salud Carlos III (Spanish Ministry of Science and Innovation and European Commision, European Regional Development Fund). DLS and FE-SEM equipment acquisition funded by Generalitat Valenciana—Conselleria d'Educació Investigació Cultura i Esport and EUFEDER “Una forma de hacer Europa” (GVA-IDIFEDER 2018/020)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Development of A New Delivery System Based on Drug-Loadable Electrospun Nanofibers for Psoriasis Treatment

  • Martínez-Ortega, Leticia
  • Mira, Amalia
  • Fernández-Carvajal, Asia
  • Reyes Mateo, Carmen
  • Mallavia, Ricardo
  • Falcó, Alberto
Psoriasis is a chronic autoimmune systemic disease with an approximate incidence of 2% worldwide; it is commonly characterized by squamous lesions on the skin that present the typical pain, stinging, and bleeding associated with an inflammatory response. In this work, poly(methyl vinyl ether-alt-maleic ethyl monoester) (PMVEMA-ES) nanofibers have been designed as a delivery vehicle for three therapeutic agents with palliative properties for the symptoms of this disease (salicylic acid, methyl salicylate, and capsaicin). For such a task, the production of these nanofibers by means of the electrospinning technique has been optimized. Their morphology and size have been characterized by optical microscopy and scanning electron microscopy (SEM). By selecting the optimal conditions to achieve the smallest and most uniform nanofibers, approximate diameters of up to 800–900 nm were obtained. It was also determined that the therapeutic agents that were used were encapsulated with high efficiency. The analysis of their stability over time by GC-MS showed no significant losses of the encapsulated compounds 15 days after their preparation, except in the case of methyl salicylate. Likewise, it was demonstrated that the therapeutic compounds that were encapsulated conserved, and even improved, their capacity to activate the transient receptor potential cation channel 1 (TRPV1) channel, which has been associated with the formation of psoriatic lesions., This research was funded by the Spanish Ministerio de Economía y Competitividad grant numbers MAT-2017-86805-R and MAT-2014-53282-R., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

L-Menthol-Loadable Electrospun Fibers of PMVEMA Anhydride for Topical Administration

  • Mira, Amalia
  • Rubio, M.
  • Alarcón, David
  • Rodríguez-Cañas, Enrique
  • Fernández-Carvajal, Asia
  • Falcó, Alberto
  • Mallavia, Ricardo
Poly(methyl vinyl ether-alt-maleic anhydride) (PMVEMA) of 119 and 139 molecular weights (P119 and P139, respectively) were electrospun to evaluate the resulting fibers as a topical delivery vehicle for (L-)menthol. Thus, electrospinning parameters were optimized for the production of uniform bead-free fibers from 12% w/w PMVEMA (±2.3% w/w menthol) solutions, and their morphology and size were characterized by field emission scanning electron microscopy (FESEM). The fibers of P119 (F119s) and P139 (F139s) showed average diameter sizes of approximately 534 and 664 nm, respectively, when unloaded, and 837 and 1369 nm when loaded with menthol. The morphology of all types of fibers was cylindrical except for F139s, which mostly displayed a double-ribbon-like shape. Gas chromatography-mass spectrometry (GC-MS) analysis determined that not only was the menthol encapsulation efficiency higher in F139s (92% versus 68% in F119s) but also that its stability over time was higher, given that in contrast with F119s, no significant losses in encapsulated menthol were detected in the F139s after 10 days post-production. Finally, in vitro biological assays showed no significant induction of cytotoxicity for any of the experimental fibers or in the full functionality of the encapsulated menthol, as it achieved equivalent free-menthol levels of activation of its specific receptor, the (human) transient receptor potential cation channel subfamily M (melastatin) member 8 (TRPM8)., This research was funded by the Spanish Ministry of Economy and Competitiveness and European ERDF Funds (MCIU/AEI/FEDER, EU) (RTI2018-097189-B-C21 to A.F.-C., RTI2018-101969-J-I00 to A.F., and MAT-2017-86805-R to R.M.). E.R.-C. is a recipient of a PTA contract from the Spanish Ministry of Science and Innovation (PTA2018-015394-I). The FESEM equipment used in this work was funded by Generalitat Valenciana (Spain) and co-financed with ERDF funds (OP ERDF of Comunitat Valenciana (Spain) GVA-IDIFEDER_2018/020 “Una forma de hacer Europa”)., Peer reviewed
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Contribución de congreso (ConferenceOutput)

Tailoring the plasmonic properties of gold-liposome nanohybrids as a potential powerful tool for light-mediated therapies

  • Rubio-Camacho, Marta
  • Martínez-Tomé, María José
  • Cuestas Ayllón, Carlos
  • Martínez de la Fuente, Jesús
  • Esquembre, Rocío
  • Mateo, C. Reyes
A fast and environmentally-friendly methodology has been developed by in situ synthesis of gold nanoparticles (AuNPs) on thermosensitive liposomes in different phase-states, obtaining nanohybrids with controllable and tunable plasmon modes within the visible/near-infrared region. Lipid phase, charge and synthesis temperature influence the final arrangement of AuNPs, so when the synthesis is performed on zwitterionic liposomes in fluid phase, discrete AuNPs with plasmon peaks in the visible region are obtained, while in gel phase AuNPs tend to aggregate forming nanoclusters, leading to plasmon bands gradually shifted to the infrared as the synthesis temperature decreases. The formed nanohybrids retain the physical properties of the liposomes (fluidity, degree of hydration, cooperativity) by maintaining the transition temperature in the mild-hyperthermia range, while preserving their light-to-heat conversion properties. Therefore, these nanohybrids can be considered excellent candidates as versatile photothermal agents with controlled drug delivery capacity, being powerful tools for light-mediated therapies.